NyxoahtoReleaseFourth Quarter and Full Year 2025 Financial Results on March 19, 2026. Mont-Saint-Guibert, Belgium - March 5 ...

Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced positive 12-month outcomes1 from its pivotal trial of the Neuspera SNM ...

Cognito Therapeutics today announced that it completed the final close of its oversubscribed Series C financing round.

Mayo Clinic researchers have identified a hidden "movement map" deep within the brain - a discovery that could help surgeons reduce side effects from epilepsy procedures and guide future treatments ...

Mayo Clinic researchers have identified a hidden "movement map" deep within the brain—a discovery that could help surgeons ...

FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal clinical study was selected for presentation on the ...

Symptoms of an overactive bladder include frequent urination, urgency and sometimes incontinence. (A urine infection needs to ...

Widespread adoption of the SWIFT approach, which reduces the number of clinic visits in the acute phase by ~70%, could alter how interventional psychiatry is delivered, improving patient retention and ...

Mayo Clinic researchers have identified a hidden "movement map" deep within the brain — a discovery that could help surgeons reduce side effects from epilepsy procedures and guide future treatments ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...

In the field of neurorehabilitation, nerve injury, resulting from trauma, disease, or iatrogenic factors, often leads to irreversible sensory, motor, and ...

Neuropsychiatric disorders, encompassing conditions such as depression, schizophrenia, bipolar disorder, and Alzheimer’s disease, represent a leading cause ...